Skip to main content
Top
Published in: Comparative Clinical Pathology 2/2018

01-03-2018 | Original Article

Comparison of efficacies of fetal bovine sera from different suppliers in cell culture experiments

Authors: Yasaman Vojgani, Abolfazl Shirazi, Saeed Zarei, Omid Yeganeh, Mahmood Jeddi-Tehrani

Published in: Comparative Clinical Pathology | Issue 2/2018

Login to get access

Abstract

Fetal bovine serum (FBS) is widely used as a culture medium supplement. A high degree of variations is observed among FBS samples produced by different suppliers. The purpose of the present study was to compare between the quality and characteristics of FBS produced at Avicenna Research Institute (ARI-FBS) and a commercial FBS. Blood samples were taken from 50 healthy bovine fetuses at 2–9 months of age. Following clotting of the blood, samples were centrifuged. Their sera were collected under sterile conditions. After irradiation, to investigate the performance and quality assurance of the serum samples, some biological properties in cell culture applications, including capacities in supporting single cell growth, proliferation, and cell viability were examined by cell cloning, MTT assay, and flow cytometry analysis. Comparison of ARI-FBS with commercial FBS showed that both of them were expedient and reliable for use in culture studies. However, significant differences in growth rates of different cell lines were observed between them. Results of MTT assay showed that L929 cell line had a significantly better viability in ARI-FBS. Conversely, PC3 and SW480 cell lines were more viable in commercial FBS. In cloning experiments and flow cytometry, both sera showed similar efficiencies. ARI-FBS supported cell growth and maintained cell viabilities in a similar manner to the commercial FBS. ARI-FBS may thus be a proper alternative for commercial FBS as a growth-promoting component for successful culture of cell lines.
Literature
go back to reference Beilinson AV, Troitskii VL, Vitokhina TA, Kaulen DR, Shufer RL, Zagrebel ‘Naia TM (1961) Gamma irradiation as a sterilization factor in the process of preparation of purified sera. Zh Mikrobiol Epidemiol Immunobiol 32:6–12PubMed Beilinson AV, Troitskii VL, Vitokhina TA, Kaulen DR, Shufer RL, Zagrebel ‘Naia TM (1961) Gamma irradiation as a sterilization factor in the process of preparation of purified sera. Zh Mikrobiol Epidemiol Immunobiol 32:6–12PubMed
go back to reference Davis JM (2002) Basic cell culture : a practical approach. Oxford University Press, New York Davis JM (2002) Basic cell culture : a practical approach. Oxford University Press, New York
go back to reference Gstraunthaler G (2003) Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20(4):275–281PubMed Gstraunthaler G (2003) Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20(4):275–281PubMed
go back to reference Jochems CE, van der Valk JB, Stafleu FR, Baumans V (2002) The use of fetal bovine serum: ethical or scientific problem? Altern Lab Anim 30(2):219–227PubMed Jochems CE, van der Valk JB, Stafleu FR, Baumans V (2002) The use of fetal bovine serum: ethical or scientific problem? Altern Lab Anim 30(2):219–227PubMed
go back to reference Langdon SP (2004) Basic principles of cancer cell culture. Methods Mol Med 88:3–15PubMed Langdon SP (2004) Basic principles of cancer cell culture. Methods Mol Med 88:3–15PubMed
go back to reference Lombardo J, Fernández DC, Quattrini D, Michelin S, Smolko E (1994) Sera radiosterilization: studies and applications. Rad Phys Chem 45:275–281CrossRef Lombardo J, Fernández DC, Quattrini D, Michelin S, Smolko E (1994) Sera radiosterilization: studies and applications. Rad Phys Chem 45:275–281CrossRef
go back to reference Masters JRW (2000) Animal cell culture : a practical approach. Oxford University Press, Oxford Masters JRW (2000) Animal cell culture : a practical approach. Oxford University Press, Oxford
go back to reference Minonzio GM, Linetsky E (2014) The use of fetal bovine serum in cellular products for clinical applications: commentary. Cell R4 6:1307 Minonzio GM, Linetsky E (2014) The use of fetal bovine serum in cellular products for clinical applications: commentary. Cell R4 6:1307
go back to reference Price PJ, Gregory EA (1982) Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement. In Vitro 18(6):576–584CrossRefPubMed Price PJ, Gregory EA (1982) Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement. In Vitro 18(6):576–584CrossRefPubMed
go back to reference Shah G (1999) Why do we still use serum in the production of biopharmaceuticals? Dev Biol Stand 99:17–22PubMed Shah G (1999) Why do we still use serum in the production of biopharmaceuticals? Dev Biol Stand 99:17–22PubMed
go back to reference Wessman SJ, Levings RL (1999) Benefits and risks due to animal serum used in cell culture production. Dev Biol Stand 99:3–8PubMed Wessman SJ, Levings RL (1999) Benefits and risks due to animal serum used in cell culture production. Dev Biol Stand 99:3–8PubMed
Metadata
Title
Comparison of efficacies of fetal bovine sera from different suppliers in cell culture experiments
Authors
Yasaman Vojgani
Abolfazl Shirazi
Saeed Zarei
Omid Yeganeh
Mahmood Jeddi-Tehrani
Publication date
01-03-2018
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 2/2018
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-017-2622-0

Other articles of this Issue 2/2018

Comparative Clinical Pathology 2/2018 Go to the issue